Smart Oximetry Devices Market Report 2026

The smart oximetry devices market size has grown strongly in recent years. It will grow from $3.07 billion in 2025 to $3.37 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to early adoption in hospitals, clinical validation of spo2 monitoring, integration with bedside monitors, regulatory approvals for pulse oximeters, expansion of critical care infrastructure.

The smart oximetry devices market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, growing adoption of remote patient monitoring, rising demand for home healthcare devices, expansion of telehealth services, increasing geriatric population. Major trends in the forecast period include technology advancements in sensor accuracy, innovations in wearable oximetry devices, developments in wireless and bluetooth connectivity, research and developments in multi-parameter monitoring, advancements in ai-based data analytics.

The increasing adoption of remote patient monitoring is expected to drive the growth of the smart oximetry devices market in the coming years. Remote patient monitoring involves the use of digital technologies to collect and track medical and health data from patients and electronically transmit this information to healthcare providers for evaluation and, when needed, guidance and intervention. The adoption of remote patient monitoring is rising as healthcare providers and payers increasingly depend on continuous at-home health data to manage chronic conditions more proactively, reduce hospital readmissions, and lower overall healthcare costs. Smart oximetry devices support remote patient monitoring by continuously measuring blood oxygen saturation and transmitting real-time data to healthcare professionals. They enhance patient care by enabling early detection of hypoxia, timely clinical interventions, and improved management of chronic respiratory and cardiovascular diseases. For example, in September 2025, according to the U.S. Department of Health and Human Services Office of Inspector General (OIG), a US-based government agency, spending on remote patient monitoring reached $536 million across Original Medicare, also known as Medicare fee-for-service, and Medicare Advantage, representing a 31% increase from 2023, while nearly one million Medicare beneficiaries received remote patient monitoring services, reflecting a 27% rise compared with 2023. As a result, the growing use of remote patient monitoring is fueling the growth of the smart oximetry devices market.

Major companies operating in the smart oximetry devices market are prioritizing the development of advanced monitoring solutions, such as cellular-enabled pulse oximeters, to deliver secure, real-time SpO₂ and pulse rate data to clinicians for proactive patient care. Cellular-enabled pulse oximeters are pulse oximetry devices with built-in cellular connectivity that transmit oxygen saturation (SpO₂) and pulse rate data directly to healthcare providers or cloud-based platforms in real time. For example, in August 2024, Prevounce Health, a US-based remote care management provider, introduced the Pylo OX1-LTE pulse oximeter, a clinically validated, cellular-enabled device featuring roaming 5G/4G LTE connectivity with 2G fallback, highly accurate SpO₂ and pulse rate measurements, and a bright OLED display for clear readability. The Pylo OX1-LTE also enables secure data transmission directly to remote monitoring platforms and integrates with third-party health software, supporting large-scale remote patient monitoring programs.

In February 2025, Masimo Corporation, a US-based provider of patient monitoring and non-invasive sensor technologies, acquired SpectraSense Inc. for an undisclosed amount. Through this acquisition, Masimo aims to enhance the performance and accuracy of its pulse oximetry sensors by incorporating SpectraSense’s patented multi-wavelength sensing technology, thereby reinforcing its competitive position across clinical and consumer health monitoring markets. SpectraSense Inc. is a US-based developer of multispectral sensing solutions for oximetry devices.

Major companies operating in the smart oximetry devices market are Medtronic plc, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Masimo Corporation, Nihon Kohden Corporation, Lepu Medical Technology Co. Ltd., Contec Medical Systems Co. Ltd., Beurer GmbH, Heal Force Bio-Meditech Holdings Ltd., Edan Instruments Inc., Biolight Meditech Co. Ltd., Omron Healthcare Co. Ltd., Nonin Medical Inc., Viatom Technology Co. Ltd., A&D Company Limited, iHealth Labs Inc., Smiths Medical International Ltd., Wellue Health Inc., Creative Medical Technology Co. Ltd., Berry Global Healthcare, Oxitone Medical Ltd., Movano Health Inc., ChoiceMMed America Corp.

North America was the largest region in the smart oximetry devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart oximetry devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart oximetry devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have created cost and supply chain challenges for the single-detector gamma camera and smart oximetry devices market by increasing prices of imported imaging components, sensors, and electronic modules. these impacts have particularly affected hospital-grade gamma cameras and advanced wireless oximeters, with asia-pacific and north america facing the greatest exposure due to reliance on cross-border manufacturing. higher tariffs have temporarily slowed procurement cycles in hospitals and diagnostic imaging centers. however, tariffs have also encouraged local manufacturing, regional sourcing strategies, and investments in cost-efficient device innovation, supporting long-term market resilience.

Smart oximetry devices are advanced digital tools designed to measure blood oxygen saturation and pulse rate through integrated sensors and wireless connectivity. They enable continuous, real-time monitoring and transmit data to connected platforms, improving visibility into an individual’s respiratory and cardiovascular condition. These devices support early identification of abnormalities and facilitate timely medical decision-making through automated alerts and data analytics.

The primary product types of smart oximetry devices are fingertip oximeters, handheld oximeters, wrist-worn oximeters, tabletop or bedside oximeters, and others. Fingertip oximeters are compact, non-invasive devices used to measure blood oxygen saturation and pulse rate through a fingertip sensor. These devices are based on conventional, Bluetooth-enabled, and Wi-Fi-enabled technologies, distributed through online and offline channels, among end users including hospitals and clinics, homecare settings, ambulatory surgical centers, and others.

The smart oximetry devices market consists of sales of wearable pulse oximeters, fingertip and wrist-based oximetry sensors, wireless and Bluetooth-enabled oxygen monitoring devices, ad integrated health monitoring platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.